- Global Pharma News & Resources

Nanomedicine Market To Reach USD 343.8 Billion By 2026 | CAGR of 12.6%

: New York, United States, 31-July-2020, (Via WiredRelease), (Reports and Data) – The global nanomedicine market is expected to reach USD 343.8 billion by 2026, according to a new report by Reports and Data. Increased global incidence of cancer coupled with growing prevalence of cardiovascular diseases is likely to be the key factors governing market growth. Based on the WHO statistics, in 2018 around 18.07million new cases were registered for cancer in 2018. Additionally, cancer accounted for around 9.5 million deaths in 2018. The incidence of cancer was significantly high and lied around 48.4 percent in Asia Pacific.

Nanomedicine is being increasingly adopted for the treatment of various diseases including cancer and cardiovascular disease. Apart from improved efficacy and safety, factors such as bio-availability and ability to deliver diagnostic and therapeutic agents to targeted sites are expected to stimulate market growth.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @

The COVID-19 impact:
Covid-19’s spread has affected manufacturing and construction activities worldwide. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for producers. The producers have relied on derived demand as an intermediate commodity to rationalize production. The pandemic’s economic impact on companies and financial markets is also not favorable. Stock market volatility and decreasing global growth are anticipated, which will affect the market.  The market has experienced a downturn over the weeks, which may continue over the next few months. The Asia Pacific is the most affected region by this pandemic, with China at the center of the outbreak. Most initiatives in multiple countries have changed to a temporary halt. Development, as well as supply, is put on hold, creating losses for suppliers, dealers and customers alike.

Key participants include

Arrowhead Pharmaceuticals Inc. AMAG Pharmaceuticals, Bio-Gate AG, Celgene Corporation and Johnson & Johnson.

Get Discount on the report @

For the purpose of this report, Reports and Data have segmented into the global Nanomedicine market on the basis of type, propellants, application, and region:

For the purpose of this report, Reports and Data have segmented global Nanomedicine Market on the basis of products, drug delivery system, application and region:

Product Outlook (Revenue, USD Billion, 2018-2026)TherapeuticsRegenerative MedicineIn-vitro diagnosticsIn-vivo diagnosticVaccines

Drug Delivery System Outlook (Revenue, USD Billion, 2018-2026)NanobotsNanoghostsNanoclustersNanobubblesExosomesInjectable Nanoparticle GeneratorDendrimersLiposomesCarbon nanotubeGrapheneOthersApplication Outlook (Revenue, USD Million, 2015-2026)OncologyInfectious diseasesCardiologyOrthopedicsOthers

Regional Outlook (Revenue, USD Million; 2017-2027)

North America





Asia Pacific





Latin America


To identify the key trends in the industry, click on the link below:

Key aspects of the Nanomedicine Market Report:

The report comprises of Nanomedicine market overview, market share, demand and supply ratio, supply chain analysis, and import/export details.

The report explores different strategies and procedures undertaken by key market players that assist in making profitable decisions.

The report covers all the crucial information about the products and services of major competitors.

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web:
Direct Line: +1-212-710-1370

This content has been published by MARKETYSERS GLOBAL CONSULTING LLP company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 03-Aug-2020